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Background
Wall motion abnormalities are central to dobutamine
stress CMR but have not been studied with regadenoson.
This study was designed to compare the diagnostic perfor-
mance of regadenoson regional wall motion abnormalities
(RWMA) versus first-pass perfusion in the detection of
significant coronary artery disease (CAD).
Methods
Patients underwent regadenoson CMR that included 3
(basal, mid, apical) slices of rest and peak stress real-time
cines, with matching stress and rest first-pass perfusion,
and late gadolinium enhancement (LGE) imaging.
The reference standard for presence or absence of
CAD was derived from invasive coronary angiography
or coronary CT angiography (CTA). Invasive angiogra-
phy established significant CAD based on a threshold of
≥70% stenosis and could rule-in or exclude CAD. CTA
was only used to exclude CAD if the calcium score was
<100 and no stenosis was >30%; CT was not used to
diagnose CAD.
Two blinded, readers qualitatively scored RWM of pre
and post-regadenoson.
Results
26 of 49 patients had at least one 70% coronary artery
stenosis. The sensitivity and specificity of regadenoson
perfusion for detecting significant CAD was 92 and 91%,
respectively. In comparison, the sensitivity and specificity
of RWMA on stress imaging was 58 and 96%, respec-
tively, and a new or worsening RWMA on stress com-
pared to rest yielded a sensitivity and specificity of 38
and 100%, respectively. The sensitivity and specificity of
LGE was 65 and 87%, respectively. Inter-reader agree-
ment for RWMA was good (kappa 0.63).
Conclusions
Although sensitivity is poor, a regadenoson-induced wall
motion abnormality seen on CMR likely indicates signif-
icant CAD.
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Table 1 Comparison of diagnostic accuracy of differing
stress CMR exam components
Sensitivity Specificity Accuracy PPV NPV
Perfusion 0.92 0.91 0.92 0.92 0.91
Stress RWMA 0.58 0.96 0.76 0.94 0.67
Induced RWMA 0.42 1.00 0.69 1.00 0.61
LGE 0.65 0.87 0.76 0.85 0.69
PPV= positive predictive value; NPV= negative predictive value; RWMA=
regional wall motion abnormality; LGE= late gadolinium enhancement
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